Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 399

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 399
---
                       |     | The Current Denali Charter permits the shareholders to approve resolutions by way of unanimous written resolution.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |     | The Proposed Charter provides that any action required or permitted to be taken by the stockholders of New Semnur must be effected by a duly called annual or special meeting of such stockholders; provided, however, that prior to the Scilex Trigger Event, any action required or permitted to be taken at any annual or special meeting of stockholders of New Semnur may be taken without a meeting, without prior notice and without a vote, if a consent or consents, setting forth the action so taken, is signed by or on behalf of the holders of record of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, is delivered to New Semnur in accordance with the DGCL. |
| Advisory Proposal G — Changes in Connection with Adoption of the Proposed Charter |     | The Current Denali Charter contains various provisions applicable only to blank check companies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |     | The Proposed Charter would (i) change the post-Business Combination company’s corporate name from “Denali Capital Acquisition Corp.” to “Semnur Pharmaceuticals, Inc.” and make the post-Business Combination company’s corporate existence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

238

| Advisory Governing Documents Proposal |     | Current Denali Charter |     | Proposed Charter                                                                                                                                                          |
|                                       |     |                        |     | perpetual and (ii) remove certain provisions related to Denali’s status as a blank check company that will no longer apply upon consummation of the business combination. |

Reasons for Approval of the Advisory Governance Proposals Advisory Proposal A — Changes in Authorized Share Capital The principal purpose of this proposal is to provide for an authorized capital structure of New Semnur that will enable it to continue as an operating company governed by the DGCL and provide adequate authorized share capital to, among other things, (i) accommodate the issuance of shares of New Semnur Common Stock and New Semnur Series A Preferred Stock as stock consideration in the Business Combination, (ii) accommodate the issuance of shares of New Semnur Common Stock under any equity plans New Semnur may adopt following the consummation of the Business Combination (which authorize the issuance of shares of New Semnur Common Stock) as we determine from time to time is